Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Congenital Heart Disease (CHD): early-phase trial registry
3 of 4 indexed Congenital Heart Disease (CHD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Congenital Heart Disease (CHD): 4 US clinical trials tracked, 3 recruiting.
Congenital Heart Disease (CHD) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is HeartWorks, running 1 of these trials.
Enrollment posture brief
Registry condition congenital-heart-disease-chd
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Congenital Heart Disease (CHD) lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Congenital Heart Disease (CHD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Congenital Heart Disease (CHD) is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Cord Clamping Among Neonates With Congenital Heart Disease
Carl Backes, MD
NCT06153459
Clinical Readiness Skin Punch Biopsy Sample Collections
HeartWorks
NCT06588426
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
Starlight Cardiovascular
NCT07114718
Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)
Catherine Bollard
NCT04236479
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Congenital Heart Disease (CHD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Congenital Heart Disease (CHD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Congenital Heart Disease (CHD) page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Congenital Heart Disease (CHD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- HeartWorks sponsors the most Congenital Heart Disease (CHD) trials on record, review their full trial history before evaluating a specific study. See HeartWorks's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Congenital Heart Disease (CHD) condition card totals 4 registered trials; most-linked intervention BM-MSC; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.